Quest Laboratories Limited
Founded in June 1998, Quest Laboratories Limited produces a diverse range of pharmaceuticals, including antibiotics, antimalarials, anti-inflammatories, etc.
What Quest files
- Others37
- Important31
- Investor Meet22
- Board Meeting10
- Results3
- Updates3
Quest Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for Notice of 28th Annual General Meeting.
Quest Laboratories' board approved its 28th AGM for Sep 30, 2026, to adopt the financial results for FY26. Key decisions include re-appointing Director Smt. Tejaswini Sabarwal, appointing M/s C.H. Padliya & Co. as Statutory Auditors, and ratifying Cost Auditor fees at Rs. 50,000 p.a.
No content was provided to summarize. Please provide the company update text.
Quest Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Quest Laboratories has re-opened its trading window. The company is discontinuing voluntary quarterly financial results, reverting to statutory half-yearly disclosures for SME-listed entities. Consequently, the Q1 results will not be announced, impacting regular investor updates.